Xiaoying Chen: Rethinking Thrombectomy in Large-Core Stroke – Insights from LASTE Analysis
Xiaoying Chen, Senior Research Fellow at The George Institute for Global Health, shared on LinkedIn about a recent article by Bertrand Lapergue et al, published in Stroke, adding:
”One of the hardest questions in acute stroke is how far we can safely extend reperfusion treatment in patients with very large established infarcts.
This secondary analysis from LASTE suggests that even patients with ASPECTS 0–2 should not be treated as a uniformly futile group, with signals for better outcomes and lower mortality after thrombectomy.
From my perspective, this is exactly where modern stroke trials need to go next: not broad over-simplifications of ‘large core’ stroke, but smarter subgroup learning that can identify where benefit persists, where bleeding risk rises, and how more precise treatment decisions can be made in real-world practice.”
Title: Endovascular Thrombectomy in Patients With Largest Baseline Infarcts (ASPECTS 0–2): An Ancillary Analysis of the LASTE Trial
Authors: Bertrand Lapergue, Caroline Arquizan, J.F. Albucher, Christophe Cognard, Hilde Henon, Nasreddine Nouri, Benjamin Gory, Sebastien Richard, Gauthier Marnat, Igor Sibon, Federico Di Maria, Mariam Annan, Grégoire Boulouis, Pere Cardona, Julien Labreuche, Vincent Costalat, Tudor Jovin
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics